Shanghai Kehua Bio-engineering (002022.SZ): Norovirus G and G Nucleic Acid Typing Detection Kit (Fluorescence PCR Method) obtained medical device registration certificate.
Shanghai Kehua Bio-engineering (002022.SZ) announced that recently, its controlling subsidiary Suzhou Tianlong Biotechnology Co., Ltd. received a medical device registration certificate (in vitro diagnostic reagent) issued by the National Medical Products Administration. The product is: "Norovirus G and G Nucleic Acid Typing Detection Kit (Fluorescence PCR Method)". This kit is used for in vitro qualitative typing detection of Norovirus G and G nucleic acid RNA in stool samples.
Shanghai Kehua Bio-engineering (002022.SZ) announced that recently, its controlling subsidiary Suzhou Tianlong Biotechnology Co., Ltd. received a medical device registration certificate (in vitro diagnostic reagent) issued by the National Medical Products Administration. The product is: "Norovirus G and G Nucleic Acid Typing Detection Kit (Fluorescence PCR Method)". This kit is used for in vitro qualitative typing detection of Norovirus G and G nucleic acid RNA in stool samples.
Related Articles
China Railway (00390): "22 Tie Gong Y4" will pay interest on October 26.
.png)
C-MER MEDICAL (03309) repurchased 60,000 shares for HK$45,000 on October 12.
Zhejiang Hengtong Holding (600226.SH) plans to inject RMB 330 million in capital increase into its subsidiary Hengtong Copper Foil.
China Railway (00390): "22 Tie Gong Y4" will pay interest on October 26.
C-MER MEDICAL (03309) repurchased 60,000 shares for HK$45,000 on October 12.
Zhejiang Hengtong Holding (600226.SH) plans to inject RMB 330 million in capital increase into its subsidiary Hengtong Copper Foil.
